NVCR : NovoCure Limited stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-27 |
|---|---|---|---|---|
| 2023 | $16.94 | $16.64 | $17.44 | -0.38% |
| 2024 | $28.18 | $18.57 | $35.54 | 65.75% |
| 2025 | $35.83 | $35.61 | $36.77 | 110.75% |
| 2026 | $43.91 | $37.76 | $50.03 | 158.27% |
| 2027 | $53.82 | $50.9 | $55.58 | 216.56% |
| 2028 | $56.03 | $55.71 | $56.18 | 229.58% |
| 2029 | $56.28 | $56.19 | $56.4 | 231.08% |
| 2030 | $56.55 | $56.42 | $56.68 | 232.66% |
| 2031 | $56.77 | $56.7 | $56.82 | 233.95% |
| 2032 | $56.84 | $56.82 | $56.85 | 234.33% |
| 2033 | $56.85 | $56.85 | $56.86 | 234.43% |
The 14 Wall Street analysts offering NovoCure Limited stock forecast in the last 6 months have average price target of
$73.0 with a high forecast of $115.0 and a low forecast of $25.0.
The average NovoCure Limited stock forecast represents a 329.41%
increase from the last price of $17.0.
From AI system, total return is 2366.52% from 4098 forecasts.
For NovoCure Limited stock forecast for 2023, 3 predictions are offered for each month of 2023 with average NovoCure Limited stock
forecast of $16.94, a high forecast of $17.44, and a low forecast of $16.64.
The average NovoCure Limited stock forecast 2023 represents a -0.38%
decrease from the last price of $17.0.
For NovoCure Limited stock forecast for 2024, 12 predictions are offered for each month of 2024 with average NovoCure Limited stock
forecast of $28.18, a high forecast of $35.54, and a low forecast of $18.57.
The average NovoCure Limited stock forecast 2024 represents a 65.75%
increase from the last price of $17.0.
For NovoCure Limited stock forecast for 2026, 12 predictions are offered for each month of 2026 with average NovoCure Limited stock
forecast of $43.91, a high forecast of $50.03, and a low forecast of $37.76.
The average NovoCure Limited stock forecast 2026 represents a 158.27%
increase from the last price of $17.0.
For NovoCure Limited stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average NovoCure Limited stock
forecast of $56.03, a high forecast of $56.18, and a low forecast of $55.71.
The average NovoCure Limited stock forecast 2028 represents a 229.58%
increase from the last price of $17.0.
For NovoCure Limited stock forecast for 2031, 12 predictions are offered for each month of 2031 with average NovoCure Limited stock
forecast of $56.77, a high forecast of $56.82, and a low forecast of $56.7.
The average NovoCure Limited stock forecast 2031 represents a 233.95%
increase from the last price of $17.0.
For NovoCure Limited stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average NovoCure Limited stock
forecast of $56.85, a high forecast of $56.86, and a low forecast of $56.85.
The average NovoCure Limited stock forecast 2033 represents a 234.43%
increase from the last price of $17.0.
Please, see more forecasts below.
NVCR : NovoCure Limited stock forecast by Wall Street Analysts
The average NovoCure Limited stock forecast from last 6 month is $73.0, and this show a -8.75% decrease in average from the prior price target of the each prediction. Also, this average forecast of $73.0 represents a -17.82% decrease from the past average forecast of $88.83, 6 months ago from 12 wall street analysts.
NovoCure Limited stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-29 | $17.73 | 4.26% |
| 2023-10-02 | $17.79 | 0.35% |
| 2023-10-03 | $17.88 | 0.54% |
| 2023-10-04 | $17.94 | 0.32% |
| 2023-10-05 | $17.81 | -0.75% |
NVCR : Long term NovoCure Limited stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $16.73 , for 2024 Sep. is $32.78 , for 2027 Sep. is $55.01 , for 2028 Sep. is $56.14 , for 2032 Sep. is $56.84 , and for 2033 Sep. is $56.86.
NVCR : NovoCure Limited stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $16.73 | -1.58% |
| 2023 Nov. | $16.64 | -0.56% |
| 2023 Dec. | $17.44 | 4.82% |
NVCR : NovoCure Limited stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $18.57 | 6.50% |
| 2024 Feb. | $19.97 | 7.52% |
| 2024 Mar. | $21.57 | 8.00% |
| 2024 Apr. | $23.46 | 8.77% |
| 2024 May. | $25.94 | 10.58% |
| 2024 Jun. | $28.60 | 10.25% |
| 2024 Jul. | $30.68 | 7.27% |
| 2024 Aug. | $32.03 | 4.41% |
| 2024 Sep. | $32.78 | 2.35% |
| 2024 Oct. | $34.02 | 3.79% |
| 2024 Nov. | $34.97 | 2.77% |
| 2024 Dec. | $35.54 | 1.63% |
NVCR : NovoCure Limited stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $35.80 | 0.75% |
| 2025 Feb. | $35.86 | 0.17% |
| 2025 Mar. | $35.81 | -0.14% |
| 2025 Apr. | $35.72 | -0.25% |
| 2025 May. | $35.65 | -0.21% |
| 2025 Jun. | $35.61 | -0.10% |
| 2025 Jul. | $35.61 | -0.00% |
| 2025 Aug. | $35.63 | 0.05% |
| 2025 Sep. | $35.64 | 0.04% |
| 2025 Oct. | $35.74 | 0.27% |
| 2025 Nov. | $36.08 | 0.96% |
| 2025 Dec. | $36.77 | 1.91% |
NVCR : NovoCure Limited stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $37.76 | 2.70% |
| 2026 Feb. | $38.82 | 2.79% |
| 2026 Mar. | $39.50 | 1.76% |
| 2026 Apr. | $40.21 | 1.79% |
| 2026 May. | $41.89 | 4.18% |
| 2026 Jun. | $43.51 | 3.88% |
| 2026 Jul. | $44.91 | 3.20% |
| 2026 Aug. | $46.08 | 2.62% |
| 2026 Sep. | $47.06 | 2.12% |
| 2026 Oct. | $48.06 | 2.13% |
| 2026 Nov. | $49.06 | 2.07% |
| 2026 Dec. | $50.03 | 1.99% |
NVCR : NovoCure Limited stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $50.90 | 1.74% |
| 2027 Feb. | $51.65 | 1.47% |
| 2027 Mar. | $52.31 | 1.29% |
| 2027 Apr. | $52.96 | 1.23% |
| 2027 May. | $53.54 | 1.11% |
| 2027 Jun. | $54.02 | 0.90% |
| 2027 Jul. | $54.42 | 0.73% |
| 2027 Aug. | $54.74 | 0.59% |
| 2027 Sep. | $55.01 | 0.49% |
| 2027 Oct. | $55.23 | 0.41% |
| 2027 Nov. | $55.42 | 0.34% |
| 2027 Dec. | $55.58 | 0.29% |
NVCR : NovoCure Limited stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $55.71 | 0.24% |
| 2028 Feb. | $55.82 | 0.19% |
| 2028 Mar. | $55.90 | 0.15% |
| 2028 Apr. | $55.97 | 0.11% |
| 2028 May. | $56.02 | 0.09% |
| 2028 Jun. | $56.06 | 0.07% |
| 2028 Jul. | $56.09 | 0.06% |
| 2028 Aug. | $56.12 | 0.05% |
| 2028 Sep. | $56.14 | 0.04% |
| 2028 Oct. | $56.16 | 0.03% |
| 2028 Nov. | $56.17 | 0.03% |
| 2028 Dec. | $56.18 | 0.02% |
NVCR : NovoCure Limited stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $56.19 | 0.02% |
| 2029 Feb. | $56.20 | 0.02% |
| 2029 Mar. | $56.22 | 0.02% |
| 2029 Apr. | $56.23 | 0.03% |
| 2029 May. | $56.25 | 0.03% |
| 2029 Jun. | $56.27 | 0.03% |
| 2029 Jul. | $56.29 | 0.03% |
| 2029 Aug. | $56.31 | 0.03% |
| 2029 Sep. | $56.33 | 0.04% |
| 2029 Oct. | $56.35 | 0.04% |
| 2029 Nov. | $56.37 | 0.04% |
| 2029 Dec. | $56.40 | 0.04% |
NVCR : NovoCure Limited stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $56.42 | 0.04% |
| 2030 Feb. | $56.44 | 0.04% |
| 2030 Mar. | $56.47 | 0.04% |
| 2030 Apr. | $56.49 | 0.04% |
| 2030 May. | $56.52 | 0.04% |
| 2030 Jun. | $56.54 | 0.04% |
| 2030 Jul. | $56.57 | 0.04% |
| 2030 Aug. | $56.59 | 0.04% |
| 2030 Sep. | $56.61 | 0.04% |
| 2030 Oct. | $56.64 | 0.04% |
| 2030 Nov. | $56.66 | 0.04% |
| 2030 Dec. | $56.68 | 0.04% |
NVCR : NovoCure Limited stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $56.70 | 0.04% |
| 2031 Feb. | $56.72 | 0.03% |
| 2031 Mar. | $56.73 | 0.03% |
| 2031 Apr. | $56.75 | 0.03% |
| 2031 May. | $56.76 | 0.02% |
| 2031 Jun. | $56.78 | 0.02% |
| 2031 Jul. | $56.79 | 0.02% |
| 2031 Aug. | $56.79 | 0.02% |
| 2031 Sep. | $56.80 | 0.01% |
| 2031 Oct. | $56.81 | 0.01% |
| 2031 Nov. | $56.81 | 0.01% |
| 2031 Dec. | $56.82 | 0.01% |
NVCR : NovoCure Limited stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $56.82 | 0.01% |
| 2032 Feb. | $56.83 | 0.01% |
| 2032 Mar. | $56.83 | 0.01% |
| 2032 Apr. | $56.83 | 0.00% |
| 2032 May. | $56.83 | 0.00% |
| 2032 Jun. | $56.84 | 0.00% |
| 2032 Jul. | $56.84 | 0.00% |
| 2032 Aug. | $56.84 | 0.00% |
| 2032 Sep. | $56.84 | 0.00% |
| 2032 Oct. | $56.84 | 0.00% |
| 2032 Nov. | $56.85 | 0.00% |
| 2032 Dec. | $56.85 | 0.00% |
NVCR : NovoCure Limited stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $56.85 | 0.00% |
| 2033 Feb. | $56.85 | 0.00% |
| 2033 Mar. | $56.85 | 0.00% |
| 2033 Apr. | $56.85 | 0.00% |
| 2033 May. | $56.85 | 0.00% |
| 2033 Jun. | $56.85 | 0.00% |
| 2033 Jul. | $56.86 | 0.00% |
| 2033 Aug. | $56.86 | 0.00% |
| 2033 Sep. | $56.86 | 0.00% |
Frequently Asked Questions about NovoCure Limited stock forecast
Is NovoCure Limited a good long term stock?
From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock cannot be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2023 Oct. is $16.7313128471723 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2024 Sep. is $32.7821928380255 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2027 Sep. is $55.0079548759401 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2028 Sep. is $56.1381263733197 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2032 Sep. is $56.8418711494303 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to Tudal, the NovoCure Limited stock price forecast for 2033 Sep. is $56.8571306458953
Is NovoCure Limited stock overvalued?
NovoCure Limited (NVCR) stock is expected to go UP . Therefore, Tudal would say that NovoCure Limited (NVCR) stock is NOT overvalued.
Will NovoCure Limited stock price go up?
Yes. The NovoCure Limited stock price forecast for 2024 Sep. is $32.7821928380255
Is NovoCure Limited stock a good buy now?
Since closing price on 2023-09-27 is $17.0 and forecast for 2024 Sep. is $32.78, NovoCure Limited stock is a good 1 year investment.